Defective Suppressor of Cytokine Signaling 1 Signaling Contributes to the Pathogenesis of Systemic Lupus Erythematosus
Authors:
Open Access
- 16 October 2017
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 1292
Abstract
Systemic lupus erythematosus (SLE) is a complex autoimmune disease involving injuries in multiple organ systems. Exaggerated inflammatory responses are characterized as end-organ damage in patients with SLE. Although the explicit pathogenesis of SLE remains unclear, increasing evidence suggests that dysregulation of cytokine signals contributes to the progression of SLE through the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway. Activated STAT proteins translocate to the cell nucleus and induce transcription of target genes, which regulate downstream cytokine production and inflammatory cell infiltration. The suppressor of cytokine signaling 1 (SOCS1) is considered as a classical inhibitor of cytokine signaling. Recent studies have demonstrated that SOCS1 expression is decreased in patients with SLE and in murine lupus models, and this negatively correlates with the magnitude of inflammation. Dysregulation of SOCS1 signals participates in various pathological processes of SLE such as hematologic abnormalities and autoantibody generation. Lupus nephritis is one of the most serious complications of SLE, and it correlates with suppressed SOCS1 signals in renal tissues. Moreover, SOCS1 insufficiency affects the function of several other organs, including skin, central nervous system, liver, and lungs. Therefore, SOCS1 aberrancy contributes to the development of both systemic and local inflammation in SLE patients. In this review, we discuss recent studies regarding the roles of SOCS1 in the pathogenesis of SLE and its therapeutic implications.Keywords
This publication has 102 references indexed in Scilit:
- Systemic lupus erythematosus: an updateMedical Journal of Australia, 2017
- Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLEFrontiers in Immunology, 2016
- Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus ErythematosusFrontiers in Immunology, 2015
- Haematological abnormalities in systemic lupus erythematosus2014
- SOCS signaling in autoimmune diseases: Molecular mechanisms and therapeutic implicationsEuropean Journal of Immunology, 2014
- The Pathogenesis of Lupus NephritisJournal of the American Society of Nephrology, 2013
- Regulation of Janus kinases by SOCS proteinsBiochemical Society Transactions, 2013
- Roles of Pro- and Anti-Inflammatory Cytokines in the Pathogenesis of SLEJournal of Biomedicine and Biotechnology, 2012
- JAK's SOCS: A Mechanism of InhibitionImmunity, 2012
- Suppressors of cytokine signaling and immunityNature Immunology, 2003